Log in
Enquire now
‌

US Patent 12018089 Anti-CD73 antibodies and uses thereof

Patent 12018089 was granted and assigned to Incyte on June, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Incyte
Incyte
0
Date Filed
December 30, 2020
0
Date of Patent
June 25, 2024
0
Patent Applicant
Incyte
Incyte
0
Patent Application Number
17138279
0
Patent Citations
‌
US Patent 10100129 Antibodies against CD73 and uses thereof
0
‌
US Patent 9090697 Methods for treating bleeding disorders
0
‌
US Patent 9388249 Method of classifying antibody, method of identifying antigen, method of obtaining antibody or antibody set, method of constructing antibody panel and antibody or antibody set and use of the same
0
‌
US Patent 9605080 Antibodies against CD73
0
‌
US Patent 9938356 Binding molecules specific for CD73 and uses thereof
0
‌
US Patent 10287362 Binding molecules specific for CD73 and uses thereof
0
Patent Inventor Names
Juan Carlos Almagro
0
Rebecca A. Buonpane
0
Shaun M. Stewart
0
Jing Zhou
0
Horacio G. Nastri
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12018089
0
Patent Primary Examiner
‌
Nelson B Moseley, II
0
CPC Code
‌
C07K 2317/21
0
‌
C07K 2317/73
0
‌
A61P 35/00
0
‌
A61K 2039/505
0
‌
A61K 39/39558
0
‌
C07K 2317/92
0
‌
C07K 2317/76
0
‌
C07K 2317/34
0
‌
C07K 2317/33
0
‌
C07K 2317/24
0
•••

Find more entities like US Patent 12018089 Anti-CD73 antibodies and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.